Weiss Ratings Reaffirms Sell (D) Rating for Ares Commercial Real Estate (NYSE:ACRE)

Ares Commercial Real Estate (NYSE:ACREGet Free Report)‘s stock had its “sell (d)” rating restated by stock analysts at Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.

A number of other research firms have also commented on ACRE. Wall Street Zen lowered shares of Ares Commercial Real Estate from a “hold” rating to a “strong sell” rating in a report on Saturday, August 9th. Keefe, Bruyette & Woods lowered their target price on shares of Ares Commercial Real Estate from $4.80 to $4.25 and set a “market perform” rating for the company in a report on Wednesday, August 6th. Zacks Research raised shares of Ares Commercial Real Estate to a “hold” rating in a report on Monday, August 11th. Finally, UBS Group lowered their target price on shares of Ares Commercial Real Estate from $5.00 to $4.50 and set a “neutral” rating for the company in a report on Wednesday, August 6th. Five equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Reduce” and a consensus price target of $4.83.

Check Out Our Latest Report on Ares Commercial Real Estate

Ares Commercial Real Estate Stock Performance

ACRE opened at $4.43 on Wednesday. The company has a fifty day moving average price of $4.63 and a two-hundred day moving average price of $4.54. Ares Commercial Real Estate has a 52 week low of $3.35 and a 52 week high of $7.49. The firm has a market capitalization of $243.69 million, a PE ratio of -13.03 and a beta of 1.32.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. Hotchkis & Wiley Capital Management LLC raised its position in Ares Commercial Real Estate by 6.1% in the 1st quarter. Hotchkis & Wiley Capital Management LLC now owns 1,094,490 shares of the real estate investment trust’s stock valued at $5,067,000 after buying an additional 62,900 shares during the last quarter. Cura Wealth Advisors LLC grew its stake in shares of Ares Commercial Real Estate by 32.1% during the 1st quarter. Cura Wealth Advisors LLC now owns 963,485 shares of the real estate investment trust’s stock worth $4,461,000 after acquiring an additional 234,258 shares in the last quarter. Marshall Wace LLP acquired a new stake in shares of Ares Commercial Real Estate in the second quarter valued at approximately $2,685,000. BI Asset Management Fondsmaeglerselskab A S raised its holdings in shares of Ares Commercial Real Estate by 8.0% in the second quarter. BI Asset Management Fondsmaeglerselskab A S now owns 453,704 shares of the real estate investment trust’s stock valued at $2,164,000 after purchasing an additional 33,764 shares during the last quarter. Finally, Penserra Capital Management LLC lifted its position in shares of Ares Commercial Real Estate by 44.5% in the second quarter. Penserra Capital Management LLC now owns 226,919 shares of the real estate investment trust’s stock worth $1,082,000 after purchasing an additional 69,881 shares in the last quarter. 41.34% of the stock is currently owned by institutional investors.

Ares Commercial Real Estate Company Profile

(Get Free Report)

Ares Commercial Real Estate Corporation, a specialty finance company, originates and invests in commercial real estate (CRE) loans and related investments in the United States. It provides a range of financing solutions for the owners, operators, and sponsors of CRE properties. The company originates senior mortgage loans, subordinate debt and preferred equity products, mezzanine loans, and other CRE investments, including commercial mortgage-backed securities.

Read More

Analyst Recommendations for Ares Commercial Real Estate (NYSE:ACRE)

Receive News & Ratings for Ares Commercial Real Estate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ares Commercial Real Estate and related companies with MarketBeat.com's FREE daily email newsletter.